Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Association of Interleukin-1 Receptor Antagonist Gene 86bp VNTR Polymorphism with Systemic Lupus Erythematosus in South East of Iran

Milad Mohammadoo-Khorasani 1 , Saeedeh Salimi 2 , * , Ehsan Tabatabai 1 , Mahnaz Sandoughi 3 and Zahra Zakeri 3
Authors Information
1 Department of Clinical Biochemistry, Zahedan University of Medical Sciences, Zahedan, Iran
2 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
3 Department of Internal Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: October 15, 2013, 16 (12); e23400
  • Published Online: November 30, 2014
  • Article Type: Research Article
  • Received: July 20, 2013
  • Accepted: August 24, 2013

To Cite: Mohammadoo-Khorasani M, Salimi S, Tabatabai E, Sandoughi M, Zakeri Z. Association of Interleukin-1 Receptor Antagonist Gene 86bp VNTR Polymorphism with Systemic Lupus Erythematosus in South East of Iran, Zahedan J Res Med Sci. 2013 ; 16(12):e23400.

Abstract
Copyright © 2014 Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
Footnotes
References
  • 1. Zhang J, Deng J, Zhang C, Lu Y, Liu L, Wu Q, et al. Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population. Clin Chim Acta. 2010; 411(11-12): 878-81[DOI][PubMed]
  • 2. Lee YH, Ota F, Kim-Howard X, Kaufman KM, Nath SK. APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility. Rheumatology (Oxford). 2007; 46(8): 1274-6[DOI][PubMed]
  • 3. Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus. 2006; 15(11): 715-9[PubMed]
  • 4. Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006; 1: 6[DOI][PubMed]
  • 5. Sawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J, et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis. 2008; 67(4): 458-61[DOI][PubMed]
  • 6. Horiuchi T, Washio M, Kiyohara C, Tsukamoto H, Tada Y, Asami T, et al. Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study. Rheumatology (Oxford). 2009; 48(9): 1045-9[DOI][PubMed]
  • 7. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 1998; 16: 27-55[DOI][PubMed]
  • 8. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993; 91(4): 403-4[PubMed]
  • 9. Nasiri H, Forouzandeh M, Rasaee MJ, Rahbarizadeh F. Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal. 2005; 19(6): 229-32[DOI][PubMed]
  • 10. Gabay C, Arend WP. Treatment of rheumatoid arthritis with IL-1 inhibitors. Springer Semin Immunopathol. 1998; 20(1-2): 229-46[PubMed]
  • 11. Koenig KF, Groeschl I, Pesickova SS, Tesar V, Eisenberger U, Trendelenburg M. Serum cytokine profile in patients with active lupus nephritis. Cytokine. 2012; 60(2): 410-6[DOI][PubMed]
  • 12. Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol. 2001; 19(5): 515-23[PubMed]
  • 13. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002; 34(2): 204-9[DOI][PubMed]
  • 14. Brugos B, Kiss E, Dul C, Gubisch W, Szegedi G, Sipka S, et al. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease. Hum Immunol. 2010; 71(9): 874-7[DOI][PubMed]
  • 15. Danis VA, Millington M, Huang Q, Hyland V, Grennan D. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. Dis Markers. 1995; 12(2): 135-9[PubMed]
  • 16. Suzuki H, Takemura H, Kashiwagi H. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum. 1995; 38(8): 1055-9[PubMed]
  • 17. Tjernstrom F, Hellmer G, Nived O, Truedsson L, Sturfelt G. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus. 1999; 8(2): 103-8[PubMed]
  • 18. D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum. 2000; 43(1): 120-8[DOI][PubMed]
  • 19. Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatol Int. 2004; 24(3): 133-6[DOI][PubMed]
  • 20. Huang CM, Wu MC, Wu JY, Tsai FJ. Interleukin-1 receptor antagonist gene polymorphism in chinese patients with systemic lupus erythematosus. Clin Rheumatol. 2002; 21(3): 255-7[PubMed]
  • 21. Parks CG, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis. 2004; 63(1): 91-4[PubMed]
  • 22. Tsai LJ, Lan JL, Lin CY, Hsiao SH, Tsai LM, Tsai JJ. The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus. Tissue Antigens. 2006; 68(6): 493-501[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments